Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Axthelm Michael K."" wg kryterium: Autor


Tytuł :
Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
Autorzy :
Bochart RM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Busman-Sahay K; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Bondoc S; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Morrow DW; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ortiz AM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Fischer MB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Shiel O; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Swanson T; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Shriver-Munsch CM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Crank HB; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Armantrout KM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Barber-Axthelm AM; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Langner C; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Moats CR; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Labriola CS; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
MacAllister R; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Axthelm MK; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Brenchley JM; Barrier Immunity Section, Lab of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United State of America.
Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Estes JD; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Hansen SG; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Smedley JV; Infectious Disease Resource, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, and Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 May 10; Vol. 17 (5), pp. e1009565. Date of Electronic Publication: 2021 May 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
Autorzy :
Verweij MC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Iyer R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
John N; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Scholz I; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Womack J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Abdulhaqq S; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Shao J; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Edlefsen PT; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory, Frederick, MD 21702, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Apr 30; Vol. 372 (6541). Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
Autorzy :
Okoye AA; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Duell DD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Fukazawa Y; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Varco-Merth B; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Marenco A; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Behrens H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Chaunzwa M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Selseth AN; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Geleziunas R; Gilead Sciences, Inc., Foster City, California, USA.
Pinkevych M; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia.
Davenport MP; Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia.
Busman-Sahay K; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Nekorchuk M; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Park H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Smedley J; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Estes JD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Hansen SG; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Picker LJ; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Apr 15; Vol. 131 (8).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma.
Autorzy :
Gern BH; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Adams KN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Plumlee CR; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Stoltzfus CR; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Shehata L; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Moguche AO; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
Urdahl KB; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA. Electronic address: .
Gerner MY; Department of Immunology, University of Washington, Seattle, WA 98109, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell host & microbe [Cell Host Microbe] 2021 Apr 14; Vol. 29 (4), pp. 594-606.e6. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Cytomegaloviral determinants of CD8 T cell programming and RhCMV/SIV vaccine efficacy.
Autorzy :
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Hancock MH; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Randall KT; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Taher H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Uebelhoer LS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
McArdle MR; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Papen CR; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Espinosa Trethewy R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Greene JM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Shao J; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Edlefsen PT; Population Sciences and Computational Biology Programs, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Grey F; Division of Infection and Immunity, Roslin Institute, University of Edinburgh, Edinburgh, UK.
Nelson JA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.
Streblow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA. .
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA. .
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2021 Mar 25; Vol. 6 (57).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Modified Adenovirus Prime-Protein Boost Clade C HIV Vaccine Strategy Results in Reduced Viral DNA in Blood and Tissues Following Tier 2 SHIV Challenge.
Autorzy :
Malherbe DC; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Vang L; Emergent BioSolutions, San Diego, CA, United States.
Mendy J; Emergent BioSolutions, San Diego, CA, United States.
Barnette PT; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Spencer DA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Reed J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Kareko BW; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Sather DN; Department of Pediatrics, University of Washington, Seattle, WA, United States.; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Pandey S; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Wibmer CK; Centre for HIV and STIs, National Institute for Communicable Diseases, of the National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Robins H; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Fuller DH; Department of Microbiology, University of Washington, Seattle, WA, United States.
Park B; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Lakhashe SK; Department of Virology and Immunology, Southwest National Primate Research Center, San Antonio, TX, United States.; Texas Biomedical Research Institute, San Antonio, TX, United States.
Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Axthelm MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Ruprecht RM; Department of Virology and Immunology, Southwest National Primate Research Center, San Antonio, TX, United States.; Texas Biomedical Research Institute, San Antonio, TX, United States.
Moore PL; Centre for HIV and STIs, National Institute for Communicable Diseases, of the National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Division of Medical Virology, Department of Pathology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Sacha JB; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.; Molecular Microbiology and Immunology, School of Medicine, Oregon Health & Science University, Portland, OR, United States.
Hessell AJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.
Alexander J; Emergent BioSolutions, San Diego, CA, United States.
Haigwood NL; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States.; Molecular Microbiology and Immunology, School of Medicine, Oregon Health & Science University, Portland, OR, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 15; Vol. 11, pp. 626464. Date of Electronic Publication: 2021 Feb 15 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Myelin-specific T cells in animals with Japanese macaque encephalomyelitis.
Autorzy :
Govindan AN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Fitzpatrick KS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Manoharan M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Tagge I; Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA.; Montreal Neurological Institute, McGill University, Montreal, QC, USA.
Kohama SG; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA.
Ferguson B; Division of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Peterson SM; Division of Genetics, Oregon National Primate Research Center, Beaverton, OR, USA.
Wong GS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Rooney WD; Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR, USA.
Park B; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR, USA.
Bourdette DN; Department of Neurology, Multiple Sclerosis Clinic, Oregon Health & Science University, Portland, OR, USA.
Sherman LS; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA.; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
Wong SW; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, OR, USA.
Pokaż więcej
Źródło :
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Feb; Vol. 8 (2), pp. 456-470. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Czasopismo naukowe
Tytuł :
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis.
Autorzy :
Plumlee CR; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Duffy FJ; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Gern BH; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98109, USA.
Delahaye JL; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Cohen SB; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Stoltzfus CR; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Rustad TR; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Aitchison JD; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Sherman DR; Department of Microbiology, University of Washington, Seattle, WA 98109, USA.
Ganusov VV; Department of Microbiology, University of Tennessee, Knoxville, TN 37996, USA.
Gerner MY; Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Zak DE; Center for Infectious Disease Research, Seattle, WA 98109, USA.
Urdahl KB; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA; Department of Pediatrics, University of Washington, Seattle, WA 98109, USA; Department of Immunology, University of Washington, Seattle, WA 98109, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell host & microbe [Cell Host Microbe] 2021 Jan 13; Vol. 29 (1), pp. 68-82.e5. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.
Autorzy :
Taher H; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Mahyari E; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Uebelhoer LS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
McArdle MR; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Moström MJ; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Bhusari A; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
E X; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Whitmer T; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Scheef EA; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Sprehe LM; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Roberts DL; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Jackson KA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Selseth AN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Cleveland-Rubeor HC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Yue Y; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Schmidt KA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Smedley J; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kowalik TF; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Stanton RJ; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Axthelm MK; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Estes JD; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Kaur A; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
Barry PA; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
Bimber BN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Malouli D; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2020 Nov 24; Vol. 16 (11), pp. e1008666. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Viremia*
Cytomegalovirus/*genetics
Cytomegalovirus Infections/*virology
Genome, Viral/*genetics
Animals ; Cell Line ; Chromosomes, Artificial, Bacterial ; Cytomegalovirus/pathogenicity ; DNA, Recombinant ; Disease Models, Animal ; Female ; Fibroblasts/virology ; Humans ; Macaca mulatta ; Male ; Mutation ; Open Reading Frames/genetics ; Phylogeny ; Species Specificity
Czasopismo naukowe
Tytuł :
Terumo spectra optia leukapheresis of cynomolgus macaques for hematopoietic stem cell and T cell collection.
Autorzy :
Wu HL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Greene JM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Swanson T; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Shriver-Munsch C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Armantrout K; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Bateman KB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Maier NM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Northrup M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Legasse AW; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Moats C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Axthelm MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Smedley J; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Maziarz RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Martin LD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Hobbs T; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Burwitz BJ; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Sacha JB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Pokaż więcej
Źródło :
Journal of clinical apheresis [J Clin Apher] 2020 Sep 17. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Autorzy :
Wu HL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Weber WC; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Shriver-Munsch C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Swanson T; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Northrup M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Price H; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Armantrout K; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Robertson-LeVay M; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Reed JS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Bateman KB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Mahyari E; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Thomas A; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Junell SL; Department of Radiation Medicine, Division of Medical Physics, Oregon Health & Science University, Portland, Oregon.
Hobbs TR; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Martin LD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
MacAllister R; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Bimber BN; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Slifka MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Legasse AW; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Moats C; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Axthelm MK; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Smedley J; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Lewis AD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Colgin L; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Meyers G; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Maziarz RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Burwitz BJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Stanton JJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Sacha JB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon.
Pokaż więcej
Źródło :
Xenotransplantation [Xenotransplantation] 2020 Jul; Vol. 27 (4), pp. e12578. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
Czasopismo naukowe
Tytuł :
MHC-E-Restricted CD8 T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.
Autorzy :
Burwitz BJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Hashiguchi PK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Mansouri M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Meyer C; Vir Biotechnology, Portland, OR 97239.
Gilbride RM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Biswas S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Womack JL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Reed JS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Wu HL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Früh K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006; .; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Sacha JB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006; .; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006; and.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Apr 15; Vol. 204 (8), pp. 2169-2176. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Hepatitis B virus/*immunology
Hepatitis B, Chronic/*immunology
Hepatocytes/*immunology
Histocompatibility Antigens Class I/*immunology
Animals ; Hepatitis B, Chronic/virology ; Hepatocytes/virology ; Macaca mulatta
Czasopismo naukowe
Tytuł :
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.
Autorzy :
Webb GM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Molden J; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Busman-Sahay K; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Abdulhaqq S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Wu HL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Bateman KB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Reed JS; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Northrup M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Maier N; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Tanaka S; ImmunityBio, Los Angeles, California, United States of America.
Gao L; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Davey B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Carpenter BL; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Axthelm MK; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Stanton JJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Smedley J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Greene JM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Safrit JT; NantKWest, Los Angeles, California, United States of America.
Estes JD; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Skinner PJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.
Sacha JB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2020 Mar 12; Vol. 16 (3), pp. e1008339. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-Retroviral Agents/*administration & dosage
B-Lymphocytes/*drug effects
CD8-Positive T-Lymphocytes/*drug effects
HIV Infections/*drug therapy
Interleukin-15/*antagonists & inhibitors
Killer Cells, Natural/*drug effects
Proteins/*administration & dosage
Animals ; B-Lymphocytes/cytology ; B-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/cytology ; CD8-Positive T-Lymphocytes/immunology ; Cell Movement/drug effects ; Disease Models, Animal ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/physiopathology ; HIV-1/drug effects ; HIV-1/physiology ; Humans ; Interleukin-15/genetics ; Interleukin-15/immunology ; Killer Cells, Natural/cytology ; Killer Cells, Natural/immunology ; Lymph Nodes/drug effects ; Lymph Nodes/immunology ; Macaca mulatta ; Recombinant Fusion Proteins ; Simian Acquired Immunodeficiency Syndrome/drug therapy ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/physiopathology ; Simian Acquired Immunodeficiency Syndrome/virology ; Simian Immunodeficiency Virus/drug effects ; Simian Immunodeficiency Virus/physiology ; Virus Latency/drug effects
Czasopismo naukowe
Tytuł :
Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis.
Autorzy :
Estep RD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Govindan AN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Manoharan M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Li H; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Fei SS; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Park BS; Oregon Health & Science University-Portland State University School of Public Health, Portland, Oregon, United States of America.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Wong SW; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Bioinformatics & Biostatistics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Feb 04; Vol. 15 (2), pp. e0228484. Date of Electronic Publication: 2020 Feb 04 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Gene Expression Profiling/*veterinary
Herpesviridae Infections/*veterinary
Rhadinovirus/*pathogenicity
Tumor Virus Infections/*veterinary
Animals ; CX3C Chemokine Receptor 1/genetics ; Cell Transformation, Neoplastic/genetics ; Cytidine Deaminase/genetics ; Gene Expression Regulation, Neoplastic ; Glypicans/genetics ; Herpesviridae Infections/genetics ; Lymphoid Tissue/metabolism ; Macaca mulatta ; Sequence Analysis, RNA/veterinary ; Tumor Virus Infections/genetics ; Virus Latency ; Virus Replication ; ras Proteins/genetics
Czasopismo naukowe
Tytuł :
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity.
Autorzy :
Shapiro MB; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Cheever T; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Malherbe DC; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.; University of Texas Medical Branch, Galveston, TX, USA.
Pandey S; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Reed J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Yang ES; Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA.
Wang K; Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA.
Pegu A; Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA.
Chen X; Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA.
Siess D; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Burke D; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Henderson H; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Lewinsohn R; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Fischer M; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Stanton JJ; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Axthelm MK; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Kahl C; Molecular Virology Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.; Atara Biotherapeutics, Thousand Oaks, CA, USA.
Park B; Biostatistics & Bioinformatics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Lewis AD; Division of Comparative Medicine, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Sacha JB; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.
Mascola JR; Vaccine Research Center, NIAID/NIH, Bethesda, MD, USA.
Hessell AJ; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Haigwood NL; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA. .; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Jan 07; Vol. 11 (1), pp. 70. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Anti-HIV Agents/*administration & dosage
Antibodies, Neutralizing/*administration & dosage
HIV Antibodies/*administration & dosage
Infectious Disease Transmission, Vertical/*prevention & control
Simian Acquired Immunodeficiency Syndrome/*prevention & control
Adaptive Immunity ; Animals ; Disease Models, Animal ; Female ; HIV Infections/immunology ; HIV Infections/prevention & control ; HIV Infections/transmission ; HIV-1/immunology ; HIV-1/physiology ; Humans ; Macaca ; Macaca mulatta ; Male ; Post-Exposure Prophylaxis ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/transmission ; Simian Immunodeficiency Virus/immunology ; Simian Immunodeficiency Virus/physiology
Czasopismo naukowe
Tytuł :
Characterization of a live-attenuated HCMV-based vaccine platform.
Autorzy :
Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
van den Worm S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Batavia Biosciences B.V., Zernikedreef 16, 2333 CL, Leiden, Netherlands.
Crawford L; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Perez W; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Kreklywich C; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Ratts R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
Marshall EE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.; Vir Biotechnology, 4640, SW Macadam Avenue, Portland, OR, 97239, USA.
Malouli D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Streblow D; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Nelson JA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
Früh K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, 97006, USA. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2019 Dec 17; Vol. 9 (1), pp. 19236. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytomegalovirus*/genetics
Cytomegalovirus*/immunology
Cytomegalovirus Infections*/genetics
Cytomegalovirus Infections*/immunology
Cytomegalovirus Infections*/prevention & control
Cytomegalovirus Vaccines*/genetics
Cytomegalovirus Vaccines*/immunology
Animals ; Cell Line, Tumor ; Human Umbilical Vein Endothelial Cells ; Humans ; Mice ; Mice, Inbred NOD ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
Czasopismo naukowe
Tytuł :
Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Autorzy :
Okoye AA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
DeGottardi MQ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Fukazawa Y; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Vaidya M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Abana CO; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Konfe AL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Fachko DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Duell DM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Li H; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Lum R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Gao L; Division of Biostatistics, Department of Public Health and Preventative Medicine, Oregon Health & Science University, Portland, OR 97239; and.
Park BS; Division of Biostatistics, Department of Public Health and Preventative Medicine, Oregon Health & Science University, Portland, OR 97239; and.
Skalsky RL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Lewis AD; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Lifson JD; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
Wong SW; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006; .; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2019 Dec 01; Vol. 203 (11), pp. 2928-2943. Date of Electronic Publication: 2019 Oct 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Interleukin-15/*immunology
Macaca mulatta/*immunology
Signal Transduction/*immunology
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; Female ; Male ; Simian Immunodeficiency Virus/pathogenicity
Czasopismo naukowe
Tytuł :
Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8 T Cells in Nonhuman Primates.
Autorzy :
Abdulhaqq SA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Wu H; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Schell JB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Hammond KB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Reed JS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Legasse AW; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA.
Axthelm MK; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA.
Park BS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Asokan A; Department of Surgery, Duke University, Durham, North Carolina, USA.
Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Hansen SG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
Sacha JB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA .; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2019 Sep 12; Vol. 93 (19). Date of Electronic Publication: 2019 Sep 12 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
ATP-Binding Cassette Transporters/*antagonists & inhibitors
CD8-Positive T-Lymphocytes/*immunology
Histocompatibility Antigens Class I/*metabolism
SAIDS Vaccines/*immunology
Simian Immunodeficiency Virus/*immunology
Animals ; Enzyme Inhibitors/metabolism ; Macaca mulatta ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; SAIDS Vaccines/administration & dosage ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Tytuł :
Interferon-Gamma test for the detection of Mycobacterium tuberculosis complex infection in Macaca mulatta and other non-human primates.
Autorzy :
Yee JL; California National Primate Research Center, University of California, Davis, California.
Prongay K; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Miles B; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Smedley J; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Hansen SG; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Axthelm MK; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Ardeshir A; California National Primate Research Center, University of California, Davis, California.
Van Rompay KKA; California National Primate Research Center, University of California, Davis, California.
Timmel G; Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, Oregon.
Roberts JA; California National Primate Research Center, University of California, Davis, California.
Pokaż więcej
Źródło :
Journal of medical primatology [J Med Primatol] 2019 Aug; Vol. 48 (4), pp. 260-263. Date of Electronic Publication: 2019 May 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Macaca mulatta*
Enzyme-Linked Immunosorbent Assay/*veterinary
Interferon-gamma Release Tests/*veterinary
Monkey Diseases/*diagnosis
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis/*diagnosis
Animals ; Enzyme-Linked Immunosorbent Assay/methods ; Interferon-gamma Release Tests/methods
Czasopismo naukowe
Tytuł :
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.
Autorzy :
Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Marshall EE; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Bae JY; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Womack J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Shao J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Reed JS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Burwitz BJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. .
Pokaż więcej
Źródło :
Science translational medicine [Sci Transl Med] 2019 Jul 17; Vol. 11 (501).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytomegalovirus/*immunology
Cytomegalovirus Vaccines/*immunology
SAIDS Vaccines/*immunology
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Acquired Immunodeficiency Syndrome/*virology
Simian Immunodeficiency Virus/*immunology
Vaccines, Attenuated/*immunology
Animals ; Genetic Vectors/metabolism ; Macaca mulatta ; Necrosis ; T-Lymphocytes/immunology ; Time Factors ; Treatment Outcome ; Vaccination
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies